We are live on !
Find out more
Simplify Asset Management Portfolio holdings
AUM
$7.19B
Turnover
25.77%
1-Year Est. Return
6.88%
This Fund
S&P 500
This Quarter Est. Return
+3.5%
1 Year Est. Return
+6.88%
3 Year Est. Return
+44.98%
5 Year Est. Return
+50.08%
10 Year Est. Return
–
AUM
$7.19B
AUM Growth
+$670M
(+10%)
Cap. Flow
+$436M
Cap. Flow % of AUM
Cap. Flow %
6.07%
Top 10 Holdings %
Top 10 Hldgs %
91.65%
Holding
163
New
20
Increased
70
Reduced
37
Closed
22
Avg Time Held
Equity + Options
1.2
years
Top 10 Avg Time Held
Equity + Options
1.5
years
Top 20 Avg Time Held
Equity + Options
1.2
years
Avg Time Held Equity only
1.2
years
Top 10 Avg Time Held Equity only
1.7
years
Top 20 Avg Time Held Equity only
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Simplify Government Money Market ETF
SBIL
|
+$311M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$93.2M |
| 3 |
UnitedHealth
UNH
|
+$14.6M |
| 4 |
Simplify China A Shares PLUS Income ETF
CAS
|
+$11.6M |
| 5 |
PureCycle Technologies
PCT
|
+$11.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$36.1M |
| 2 |
Simplify Short Term Treasury Futures Strategy ETF
TUA
|
+$14.9M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$8.67M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$8.42M |
| 5 |
Align Technology
ALGN
|
+$6.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.55% |
| 2 | Healthcare | 5.05% |
| 3 | Energy | 0.44% |
| 4 | Industrials | 0.38% |
| 5 | Technology | 0.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
AGNC Investment
AGNC
$10B
| $1.26M | 0.02% |
115,485
+12,000
| +12% | +$126K |
2023 Q3
11 quarters
|
|
77
Inventiva
IVA
$704M
| $1.18M | 0.02% |
313,483
+85,560
| +38% | +$411K |
2025 Q4
2 quarters
|
|
78
TG Therapeutics
TGTX
$8.16B
| $1.17M | 0.02% |
21,269
+5,220
| +33% | +$214K |
2024 Q4
6 quarters
|
|
79
Aquestive Therapeutics
AQST
$481M
| $1.16M | 0.02% |
278,723
+44,444
| +19% | +$187K |
2026 Q1
1 quarter
|
|
80
Full House Resorts
FLL
$36.1M
| $1.11M | 0.02% |
+397,000
| New | +$1.05M |
2026 Q2
0 quarters
|
|
81
Zevra Therapeutics
ZVRA
$603M
| $1.01M | 0.01% |
70,759
-29,871
| -30% | -$332K |
2024 Q3
7 quarters
|
|
82
Qualcomm
QCOM
$185B
| $1.01M | 0.01% |
5,471
-103
| -2% | -$19.3K |
2025 Q3
3 quarters
|
|
83
Artiva Biotherapeutics
ARTV
$288M
| $983K | 0.01% |
101,355
+78,125
| +336% | +$712K |
2026 Q1
1 quarter
|
|
84
Seagate
STX
$150B
| $955K | 0.01% |
990
+5
| +0.5% | +$3.81K |
2025 Q4
2 quarters
|
|
85
Orchestra BioMed
OBIO
$340M
| $947K | 0.01% |
219,387
| – | – |
2026 Q1
1 quarter
|
|
86
Cooper Companies
COO
$11.1B
| $945K | 0.01% |
13,182
+3,240
| +33% | +$212K |
2022 Q2
16 quarters
|
|
87
Palisade Bio
PALI
$234M
| $942K | 0.01% |
450,543
+100,543
| +29% | +$198K |
2026 Q1
1 quarter
|
|
88
Armour Residential REIT
ARR
$1.74B
| $941K | 0.01% |
53,900
| – | – |
2025 Q4
2 quarters
|
|
89
Western Digital
WDC
$132B
| $932K | 0.01% |
1,459
-74
| -5% | -$36K |
2025 Q4
2 quarters
|
|
90
Blue Owl Capital
OWL
$6.13B
| $932K | 0.01% |
+106,500
| New | +$1.01M |
2026 Q2
0 quarters
|
|
91
Merck
MRK
$354B
| $921K | 0.01% |
7,167
+623
| +10% | +$72.9K |
2026 Q1
1 quarter
|
|
92
Agilon Health
AGL
$1.49B
| $903K | 0.01% |
+8,429
| New | +$552K |
2026 Q2
0 quarters
|
|
93
Mastercard
MA
$540B
| $810K | 0.01% |
1,577
+51
| +3% | +$25.4K |
2025 Q3
3 quarters
|
|
94
Ocular Therapeutix
OCUL
$1.38B
| $796K | 0.01% |
81,051
-8,949
| -10% | -$81.1K |
2026 Q1
1 quarter
|
|
95
ExxonMobil
XOM
$733B
| $736K | 0.01% |
5,386
+515
| +11% | +$77.1K |
2025 Q3
3 quarters
|
|
96
Stryker
SYK
$114B
| $708K | 0.01% |
2,250
+540
| +32% | +$170K |
2022 Q1
17 quarters
|
|
97
Salesforce
CRM
$200B
| $692K | 0.01% |
+4,420
| New | +$777K |
2026 Q2
0 quarters
|
|
98
Chimera Investment
CIM
$680M
| $681K | 0.01% |
51,025
| – | – |
2024 Q3
7 quarters
|
|
99
Boston Scientific
BSX
$65.3B
| $641K | 0.01% |
15,014
+3,690
| +33% | +$200K |
2025 Q2
4 quarters
|
|
100
GE Aerospace
GE
$323B
| $614K | 0.01% |
1,643
-24
| -1% | -$7.51K |
2025 Q3
3 quarters
|
|
Similar funds
SAM
Simplify Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, Simplify Asset Management held 163 positions worth $7.19B, up 10% from $6.52B the previous quarter. Its ten largest holdings account for 92% of the portfolio.
Simplify Asset Management deployed $436M of net new capital in Q2 2026, opening 20 new positions and adding to 70 existing holdings. Its largest new stake was Simplify China A Shares PLUS Income ETF: 428,078 shares worth $12.4M.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 95% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $36.1M trimmed.
- Simplify Asset Management's largest Q2 2026 buy was Simplify China A Shares PLUS Income ETF: 428,078 shares worth $12.4M.
- Simplify Asset Management added most to Simplify Government Money Market ETF in Q2 2026, an estimated $311M increase.
- Simplify Asset Management's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $36.1M.
- Simplify Asset Management fully exited Regeneron Pharmaceuticals in Q2 2026, selling an estimated $8.42M.
- Simplify Asset Management's ten largest holdings make up 92% of its $7.19B portfolio in Q2 2026.
- Simplify Asset Management opened 20 new positions and closed 22 in Q2 2026.
- Simplify Asset Management's portfolio value rose 10% quarter-over-quarter to $7.19B.
Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.